The role of complement in normal pregnancy and preeclampsia

Preeclampsia affects 3-4% of pregnancies with adverse effects for both mother and child. Minimal therapeutic options are available, and biomarkers are urgently needed to identify those at greatest risk early in the pregnancy. Both the innate and adaptive immune systems are well regulated during norm...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard M. Burwick, Anuja Java, Jean F. Regal
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1643896/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418781328146432
author Richard M. Burwick
Anuja Java
Jean F. Regal
author_facet Richard M. Burwick
Anuja Java
Jean F. Regal
author_sort Richard M. Burwick
collection DOAJ
description Preeclampsia affects 3-4% of pregnancies with adverse effects for both mother and child. Minimal therapeutic options are available, and biomarkers are urgently needed to identify those at greatest risk early in the pregnancy. Both the innate and adaptive immune systems are well regulated during normal pregnancy including the complement system. A functioning complement system with some degree of complement activation participates in proper placental development, ensuring a healthy pregnancy and assisting with host defense. However, aberrant complement activation can lead to adverse pregnancy outcomes such as preeclampsia. An overview of the complement system will be presented, along with review of the pre-clinical literature in animal models providing evidence for complement involvement in maintaining a normal pregnancy and contributing to symptoms of preeclampsia. In addition, clinical studies with evaluation of complement biomarkers in plasma and urine implicate complement dysregulation in the pathophysiology of subtypes of preeclampsia including HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. Recent studies on the genetics of complement dysregulation in preeclampsia will be reviewed, along with updates on use of recently developed complement therapeutics. The potential utility of evaluating complement activation or manipulating complement during pregnancy will be discussed in view of the successful use of complement therapeutics in pregnancy in other immune diseases.
format Article
id doaj-art-99f73d3925a045e592ef19215dd9dfd8
institution Kabale University
issn 1664-3224
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-99f73d3925a045e592ef19215dd9dfd82025-08-20T03:32:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16438961643896The role of complement in normal pregnancy and preeclampsiaRichard M. Burwick0Anuja Java1Jean F. Regal2Maternal Fetal Medicine, San Gabriel Valley Perinatal Medical Group, Pomona Valley Hospital Medical Center, Pomona, CA, United StatesDivision of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, United StatesPreeclampsia affects 3-4% of pregnancies with adverse effects for both mother and child. Minimal therapeutic options are available, and biomarkers are urgently needed to identify those at greatest risk early in the pregnancy. Both the innate and adaptive immune systems are well regulated during normal pregnancy including the complement system. A functioning complement system with some degree of complement activation participates in proper placental development, ensuring a healthy pregnancy and assisting with host defense. However, aberrant complement activation can lead to adverse pregnancy outcomes such as preeclampsia. An overview of the complement system will be presented, along with review of the pre-clinical literature in animal models providing evidence for complement involvement in maintaining a normal pregnancy and contributing to symptoms of preeclampsia. In addition, clinical studies with evaluation of complement biomarkers in plasma and urine implicate complement dysregulation in the pathophysiology of subtypes of preeclampsia including HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. Recent studies on the genetics of complement dysregulation in preeclampsia will be reviewed, along with updates on use of recently developed complement therapeutics. The potential utility of evaluating complement activation or manipulating complement during pregnancy will be discussed in view of the successful use of complement therapeutics in pregnancy in other immune diseases.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1643896/fullinnate immunitycomplementpregnancypreeclampsiapregnancy lossfetal development
spellingShingle Richard M. Burwick
Anuja Java
Jean F. Regal
The role of complement in normal pregnancy and preeclampsia
Frontiers in Immunology
innate immunity
complement
pregnancy
preeclampsia
pregnancy loss
fetal development
title The role of complement in normal pregnancy and preeclampsia
title_full The role of complement in normal pregnancy and preeclampsia
title_fullStr The role of complement in normal pregnancy and preeclampsia
title_full_unstemmed The role of complement in normal pregnancy and preeclampsia
title_short The role of complement in normal pregnancy and preeclampsia
title_sort role of complement in normal pregnancy and preeclampsia
topic innate immunity
complement
pregnancy
preeclampsia
pregnancy loss
fetal development
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1643896/full
work_keys_str_mv AT richardmburwick theroleofcomplementinnormalpregnancyandpreeclampsia
AT anujajava theroleofcomplementinnormalpregnancyandpreeclampsia
AT jeanfregal theroleofcomplementinnormalpregnancyandpreeclampsia
AT richardmburwick roleofcomplementinnormalpregnancyandpreeclampsia
AT anujajava roleofcomplementinnormalpregnancyandpreeclampsia
AT jeanfregal roleofcomplementinnormalpregnancyandpreeclampsia